Kidney fibrosis imaging with Ga-68 FAPI PET/CT in CKD
Official title: Evaluation of Renal Renal Fibrosis Vie FAPI-PET-CT: a Prospective Non-randomized Open-label Single-center Pilot Study
Run by Medical University of Vienna · NCT07712679 · Data updated 2026-11-12
This study tests whether a Ga-68 FAPI PET/CT scan can reflect how much fibrosis is in the kidneys of people with chronic kidney disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 1 site (Vienna, State of Vienna) |
| Status | Recruiting |
| Started | September 5, 2025 |
| Main results expected | September 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT07712679 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with chronic kidney disease who have a prior histological workup of a native kidney and can undergo PET/CT imaging.
✕Probably not a fit
Patients without sufficient kidney fibrosis signal on imaging or without compatible histology may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers are evaluating the use of 68Ga-DOTA.SA.FAPi PET/CT to measure kidney fibrosis in CKD patients. The imaging approach aims to provide a noninvasive proxy for fibrosis that traditionally requires biopsy. The study will correlate tracer uptake with histological fibrosis from native kidney tissue and assess feasibility in patients with existing histology. It is conducted at the General Hospital Vienna with patients who have a histological workup of the native kidney. No results are yet reported from this interventional imaging study.
Why it matters
Potential benefit: If successful, this imaging method could reduce the need for invasive kidney biopsies and improve monitoring of fibrosis progression in CKD patients.
How similar studies have gone: Earlier small studies in CKD and other fibrotic conditions suggest PET tracers like FAPI can reflect fibrosis, but CKD evidence remains preliminary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Histological workup of native kidney present Exclusion Criteria: * Age \<18 * Pregnancy
Where it's running
-
General hospital Vienna
Vienna, State of Vienna, Austria Recruiting
Study contacts
- Principal investigator: Rainer Oberbauer, MD, PhD — Medical University of Vienna, Internal Medicine III, Department of Nephrology and Dialysis
- Study coordinator: Constantin N Aschauer, MD
- Email: constantin.aschauer@muv.ac.at
- Phone: 004314040043910
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observational look at how Kremezin works in adults with advanced chronic kidney disease
This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.
-
Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China
This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
Arterial stiffness in children and young people with CKD and hypertension
This study will test whether arterial stiffness is higher in children and young people with chronic kidney disease and high blood pressure compared with their peers, using a one-time assessment and follow-up for those with high BP.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.